Swiss National Bank’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $346M | Buy |
|
|||||
|
2025
Q1 | $352M | Sell |
|
|||||
|
2024
Q4 | $294M | Sell |
|
|||||
|
2024
Q3 | $356M | Buy |
|
|||||
|
2024
Q2 | $358M | Sell |
|
|||||
|
2024
Q1 | $323M | Sell |
|
|||||
|
2023
Q4 | $328M | Sell |
|
|||||
|
2023
Q3 | $288M | Sell |
|
|||||
|
2023
Q2 | $327M | Sell |
|
|||||
|
2023
Q1 | $321M | Sell |
|
|||||
|
2022
Q4 | $301M | Sell |
|
|||||
|
2022
Q3 | $321M | Buy |
|
|||||
|
2022
Q2 | $311M | Buy |
|
|||||
|
2022
Q1 | $287M | Buy |
|
|||||
|
2021
Q4 | $217M | Sell |
|
|||||
|
2021
Q3 | $186M | Sell |
|
|||||
|
2021
Q2 | $214M | Sell |
|
|||||
|
2021
Q1 | $320M | Buy |
|
|||||
|
2020
Q4 | $347M | Buy |
|
|||||
|
2020
Q3 | $378M | Buy |
|
|||||
|
2020
Q2 | $344M | Buy |
|
|||||
|
2020
Q1 | $247M | Buy |
|
|||||
|
2019
Q4 | $182M | Sell |
|
|||||
|
2019
Q3 | $147M | Buy |
|
|||||
|
2019
Q2 | $157M | Buy |
|
|||||
|
2019
Q1 | $157M | Buy |
|
|||||
|
2018
Q4 | $138M | Buy |
|
|||||
|
2018
Q3 | $157M | Sell |
|
|||||
|
2018
Q2 | $143M | Buy |
|
|||||
|
2018
Q1 | $132M | Sell |
|
|||||
|
2017
Q4 | $139M | Buy |
|
|||||
|
2017
Q3 | $140M | Buy |
|
|||||
|
2017
Q2 | $117M | Buy |
|
|||||
|
2017
Q1 | $96.1M | Buy |
|
|||||
|
2016
Q4 | $50.8M | Buy |
|
|||||
|
2016
Q3 | $59.7M | Sell |
|
|||||
|
2016
Q2 | $59.4M | Buy |
|
|||||
|
2016
Q1 | $48.6M | Buy |
|
|||||
|
2015
Q4 | $55.9M | Buy |
|
|||||
|
2015
Q3 | $45.3M | Buy |
|
|||||
|
2015
Q2 | $48.2M | Buy |
|
|||||
|
2015
Q1 | $43.2M | Buy |
|
|||||
|
2014
Q4 | $26.3M | Sell |
|
|||||
|
2014
Q3 | $25.4M | Sell |
|
|||||
|
2014
Q2 | $21.8M | Buy |
|
|||||
|
2014
Q1 | $16M | Sell |
|
|||||
|
2013
Q4 | $18.4M | Sell |
|
|||||
|
2013
Q3 | $19.7M | Buy |
|
|||||
|
2013
Q2 | $18.5M | Buy |
|